VIRACEPT (H.J. Harkins Company, Inc.)


Welcome to the PulseAid listing for the VIRACEPT drug offered from H.J. Harkins Company, Inc.. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: H.J. Harkins Company, Inc.
NON-PROPRIETARY NAME: nelfinavir mesylate
SUBSTANCE NAME: NELFINAVIR MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1997-03-14
END MARKETING DATE: 0000-00-00


VIRACEPT HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVIRACEPT from H.J. Harkins Company, Inc.
LABELER NAME: H.J. Harkins Company, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 1997-03-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52959-289_a0862d45-3327-433a-9d0d-2928a4327527
PRODUCT NDC: 52959-289
APPLICATION NUMBER: NDA020779

Other NELFINAVIR MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AGOURONVIRACEPT
H.J. Harkins Company, Inc.VIRACEPT
PD-Rx Pharmaceuticals, Inc.VIRACEPT
State of Florida DOH Central PharmacyViracept